Initial CXCR4-directed endo-radiotherapy with 177Lu- and 90Y-labeled pentixather [29] for progressive refractory MM with massive bone marrow and extra-medullary disease showed promising results, including good treatment tolerance and improved preliminary response rates. The gene discussed is CXCR4; the disease is Miyoshi myopathy.